WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

TB-500

Governed registry record

25 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Open the peptide evidence profile →

Approved source records

  1. Peptide Supplements and Their Therapeutic Applications in Sports Medicine.

    Tewari K, Liu TP, Im C, Hamad C, Petrigliano F, Cheung EC, Kremen TJ Jr. · 2026

    DOI: 10.1177/03635465261464420PMID: 42578445

  2. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

    Mendias CL, Awan TM. · 2026

    DOI: 10.1007/s40279-026-02437-0PMID: 41966639

  3. Enhancing fat graft survival: thymosin beta-4 facilitates mitochondrial transfer from ADSCs via tunneling nanotubes by upregulating the Rac/F-actin pathway.

    Zhang X, Lin Y, Li H, Wang Q, Mu D. · 2025

    DOI: 10.1016/j.freeradbiomed.2024.12.061PMID: 39761767

  4. Mechanistic study of the Tβ4/SLC7A11 signaling pathway regulating breast cancer evolution.

    Jin Z, Li H, Li J, Chang Y, Piao Z, Jin Q, Jin T. · 2025

    DOI: 10.1016/j.cellsig.2025.112111PMID: 40912522

  5. Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.

    Zhang Y, Dong Q, Bian X, Qiao Z, Cui C, Yang N, Liu J, Fu R, Zhang J, Jia L, Wu C, Guo J, Lin W, Wang J, Fan J, Li Y, Liu F, Yang B, Jia X, Gao C, Bai M, He Y, Han C, Yin D, Dou K. · 2025

    DOI: 10.1093/cvr/cvaf223PMID: 41229390

  6. Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.

    Zeng PM, Sun XY, Li Y, Wu WD, Huang J, Cao DD, Qian PJ, Ju XC, Luo ZG. · 2025

    DOI: 10.1016/j.stemcr.2025.102601PMID: 40816274

  7. The subcommissural organ regulates brain development via secreted peptides.

    Zhang T, Ai D, Wei P, Xu Y, Bi Z, Ma F, Li F, Chen XJ, Zhang Z, Zou X, Guo Z, Zhao Y, Li JL, Ye M, Feng Z, Zhang X, Zheng L, Yu J, Li C, Tu T, Zeng H, Lei J, Zhang H, Hong T, Zhang L, Luo B, Li Z, Xing C, Jia C, Li L, Sun W, Ge WP. · 2024

    DOI: 10.1038/s41593-024-01639-xPMID: 38741020

  8. Deficiency of endothelial sirtuin1 in mice stimulates skeletal muscle insulin sensitivity by modifying the secretome.

    Li Q, Zhang Q, Kim YR, Gaddam RR, Jacobs JS, Bachschmid MM, Younis T, Zhu Z, Zingman L, London B, Rauckhorst AJ, Taylor EB, Norris AW, Vikram A, Irani K. · 2023

    DOI: 10.1038/s41467-023-41351-1PMID: 37696839

  9. Thymosin Beta 4 Protects Hippocampal Neuronal Cells against PrP (106-126) via Neurotrophic Factor Signaling.

    Kim S, Choi J, Kwon J. · 2023

    DOI: 10.3390/molecules28093920PMID: 37175330

  10. Thymosin beta 4 prevents systemic lipopolysaccharide-induced plaque load in middle-age APP/PS1 mice.

    Othman O, Marshall H, Masterson M, Winlow P, Gibson G, Ding Y, Pardon MC. · 2023

    DOI: 10.1016/j.intimp.2023.109951PMID: 36878045

  11. Thymosin beta 4: A potential novel adjunct treatment for bacterial keratitis.

    Sosne G, Berger EA. · 2023

    DOI: 10.1016/j.intimp.2023.109953PMID: 37018981

  12. Thymosin beta-4 - A potential tool in healing middle ear lesions in adult mammals.

    Bako P, Lippai B, Nagy J, Kramer S, Kaszas B, Tornoczki T, Bock-Marquette I. · 2023

    DOI: 10.1016/j.intimp.2023.109830PMID: 38706788

  13. Thymosin beta 4 attenuates PrP(106-126)-induced human brain endothelial cells dysfunction.

    Song K, Han HJ, Kim S, Kwon J. · 2020

    DOI: 10.1016/j.ejphar.2019.172891PMID: 31877278

  14. Recombinant adeno-associated virus carrying thymosin beta(4) suppresses experimental colitis in mice.

    Zheng XY, Lv YF, Li S, Li Q, Zhang QN, Zhang XT, Hao ZM. · 2017

    DOI: 10.3748/wjg.v23.i2.242PMID: 28127198

  15. Thymosin Beta-4 Is Elevated in Women With Heart Failure With Preserved Ejection Fraction.

    Drum CL, Tan WKY, Chan SP, Pakkiri LS, Chong JPC, Liew OW, Ng TP, Ling LH, Sim D, Leong KG, Yeo DPS, Ong HY, Jaufeerally F, Wong RCC, Chai P, Low AF, Davidsson P, Liljeblad M, Söderling AS, Gan LM, Bhat RV, Purnamawati K, Lam CSP, Richards AM. · 2017

    DOI: 10.1161/JAHA.117.005586PMID: 28611096

  16. Loss of endogenous thymosin beta(4) accelerates glomerular disease.

    Vasilopoulou E, Kolatsi-Joannou M, Lindenmeyer MT, White KE, Robson MG, Cohen CD, Sebire NJ, Riley PR, Winyard PJ, Long DA. · 2016

    DOI: 10.1016/j.kint.2016.06.032PMID: 27575556

  17. Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma.

    Wirsching HG, Krishnan S, Florea AM, Frei K, Krayenbühl N, Hasenbach K, Reifenberger G, Weller M, Tabatabai G. · 2014

    DOI: 10.1093/brain/awt333PMID: 24355709

  18. Thymosin beta 4 ameliorates hyperglycemia and improves insulin resistance of KK Cg-Ay/J mouse.

    Zhu J, Su LP, Ye L, Lee KO, Ma JH. · 2012

    DOI: 10.1016/j.diabres.2011.12.009PMID: 22217673

  19. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications.

    Goldstein AL, Hannappel E, Sosne G, Kleinman HK. · 2012

    DOI: 10.1517/14712598.2012.634793PMID: 22074294

  20. Localization of thymosin beta-4 in tumors.

    Larsson LI, Holck S. · 2007

    DOI: 10.1196/annals.1415.005PMID: 17495241

  21. The beta-thymosin enigma.

    Sun HQ, Yin HL. · 2007

    DOI: 10.1196/annals.1415.021PMID: 17495248

  22. beta-Thymosins.

    Hannappel E. · 2007

    DOI: 10.1196/annals.1415.018PMID: 17468232

  23. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells.

    Malinda KM, Goldstein AL, Kleinman HK. · 1997

    DOI: 10.1096/fasebj.11.6.9194528PMID: 9194528

  24. Thymosin beta 4-like peptides.

    Horecker BL, Erickson-Viitanen S, Hannappel E. · 1985

    DOI: 10.1016/s0076-6879(85)16020-9PMID: 4088088

  25. Thymosin beta 4.

    Low TL, Goldstein AL. · 1985

    DOI: 10.1016/s0076-6879(85)16018-0PMID: 4088087